A phase i study of IV doxorubicin plus intraperitoneal (IP) paclitaxel and IV or IP cisplatin in endometrial cancer patients at high risk for peritoneal failure (GOG 9920): An NRG oncology/gynecologic oncology group study

D. Scott McMeekin; Michael W. Sill; Joan L. Walker; Kathleen N. Moore; Steven E. Waggoner; Premal H. Thaker; Tina Rizack; James S. Hoffman; Paula M. Fracasso

doi:10.1097/01.ogx.0000471706.11154.3b

A phase i study of IV doxorubicin plus intraperitoneal (IP) paclitaxel and IV or IP cisplatin in endometrial cancer patients at high risk for peritoneal failure (GOG 9920): An NRG oncology/gynecologic oncology group study

D. Scott McMeekin
, Michael W. Sill
, Joan L. Walker
, Kathleen N. Moore
, Steven E. Waggoner
, Premal H. Thaker
, Tina Rizack
, James S. Hoffman
, Paula M. Fracasso

Research output: Contribution to journal › Comment/debate

Original language	English
Pages (from-to)	626-628
Number of pages	3
Journal	Obstetrical and Gynecological Survey
Volume	70
Issue number	10
DOIs	https://doi.org/10.1097/01.ogx.0000471706.11154.3b
State	Published - 2015

Access to Document

10.1097/01.ogx.0000471706.11154.3b

Cite this

McMeekin, D. S., Sill, M. W., Walker, J. L., Moore, K. N., Waggoner, S. E., Thaker, P. H., Rizack, T., Hoffman, J. S., & Fracasso, P. M. (2015). A phase i study of IV doxorubicin plus intraperitoneal (IP) paclitaxel and IV or IP cisplatin in endometrial cancer patients at high risk for peritoneal failure (GOG 9920): An NRG oncology/gynecologic oncology group study. Obstetrical and Gynecological Survey, 70(10), 626-628. https://doi.org/10.1097/01.ogx.0000471706.11154.3b

@article{a793d6b5614f446a8585f2175806d506,

title = "A phase i study of IV doxorubicin plus intraperitoneal (IP) paclitaxel and IV or IP cisplatin in endometrial cancer patients at high risk for peritoneal failure (GOG 9920): An NRG oncology/gynecologic oncology group study",

author = "McMeekin, \{D. Scott\} and Sill, \{Michael W.\} and Walker, \{Joan L.\} and Moore, \{Kathleen N.\} and Waggoner, \{Steven E.\} and Thaker, \{Premal H.\} and Tina Rizack and Hoffman, \{James S.\} and Fracasso, \{Paula M.\}",

year = "2015",

doi = "10.1097/01.ogx.0000471706.11154.3b",

language = "English",

volume = "70",

pages = "626--628",

journal = "Obstetrical and Gynecological Survey",

issn = "0029-7828",

number = "10",

}

McMeekin, DS, Sill, MW, Walker, JL, Moore, KN, Waggoner, SE, Thaker, PH, Rizack, T, Hoffman, JS & Fracasso, PM 2015, 'A phase i study of IV doxorubicin plus intraperitoneal (IP) paclitaxel and IV or IP cisplatin in endometrial cancer patients at high risk for peritoneal failure (GOG 9920): An NRG oncology/gynecologic oncology group study', Obstetrical and Gynecological Survey, vol. 70, no. 10, pp. 626-628. https://doi.org/10.1097/01.ogx.0000471706.11154.3b

A phase i study of IV doxorubicin plus intraperitoneal (IP) paclitaxel and IV or IP cisplatin in endometrial cancer patients at high risk for peritoneal failure (GOG 9920): An NRG oncology/gynecologic oncology group study. / McMeekin, D. Scott; Sill, Michael W.; Walker, Joan L. et al.
In: Obstetrical and Gynecological Survey, Vol. 70, No. 10, 2015, p. 626-628.

Research output: Contribution to journal › Comment/debate

TY - JOUR

T1 - A phase i study of IV doxorubicin plus intraperitoneal (IP) paclitaxel and IV or IP cisplatin in endometrial cancer patients at high risk for peritoneal failure (GOG 9920)

T2 - An NRG oncology/gynecologic oncology group study

AU - McMeekin, D. Scott

AU - Sill, Michael W.

AU - Walker, Joan L.

AU - Moore, Kathleen N.

AU - Waggoner, Steven E.

AU - Thaker, Premal H.

AU - Rizack, Tina

AU - Hoffman, James S.

AU - Fracasso, Paula M.

PY - 2015

Y1 - 2015

UR - https://www.scopus.com/pages/publications/84944411501

U2 - 10.1097/01.ogx.0000471706.11154.3b

DO - 10.1097/01.ogx.0000471706.11154.3b

M3 - Comment/debate

AN - SCOPUS:84944411501

SN - 0029-7828

VL - 70

SP - 626

EP - 628

JO - Obstetrical and Gynecological Survey

JF - Obstetrical and Gynecological Survey

IS - 10

ER -

McMeekin DS, Sill MW, Walker JL, Moore KN, Waggoner SE, Thaker PH et al. A phase i study of IV doxorubicin plus intraperitoneal (IP) paclitaxel and IV or IP cisplatin in endometrial cancer patients at high risk for peritoneal failure (GOG 9920): An NRG oncology/gynecologic oncology group study. Obstetrical and Gynecological Survey. 2015;70(10):626-628. doi: 10.1097/01.ogx.0000471706.11154.3b

A phase i study of IV doxorubicin plus intraperitoneal (IP) paclitaxel and IV or IP cisplatin in endometrial cancer patients at high risk for peritoneal failure (GOG 9920): An NRG oncology/gynecologic oncology group study

Access to Document

Other files and links

Cite this